Daytona is main driver of growth at Optos

Optos held a seminar in London last week to present the benefits of ultra-widefield (UWF) imaging in screening diabetic retinopathy and post its latest financial results.

All but 3 per cent of the Scottish retinal imaging firm’s sales were now outside the UK, but the company’s boss praised domestic eye screening services for diabetes patients.

Roy Davis, CEO of Optos, told Optician: ‘The UK is one of the leading places for diagnosis [of diabetes]. People look at it as a model for what they would look like.

‘Globally people are looking to do more screening because all healthcare budgets are under pressure.’

For the first half of its financial year ended March 31, Optos reported headline revenue of $72.7m, up 8 per cent on an underlying basis, with an improved cash position.